1. A class of geranylquinol-derived polycyclic meroterpenoids from Arnebia euchroma against heart failure by reducing excessive autophagy and apoptosis in cardiomyocytes.
- Author
-
Zhao LH, Guo XY, Yan HW, Jiang JS, Zhang X, Yang YN, Yuan X, Sun H, and Zhang PC
- Subjects
- Rats, Animals, Molecular Structure, Structure-Activity Relationship, Dose-Response Relationship, Drug, Heart Failure drug therapy, Cardiotonic Agents pharmacology, Cardiotonic Agents chemistry, Cardiotonic Agents isolation & purification, Cell Line, Apoptosis drug effects, Myocytes, Cardiac drug effects, Myocytes, Cardiac metabolism, Autophagy drug effects, Boraginaceae chemistry, Terpenes pharmacology, Terpenes chemistry, Terpenes isolation & purification
- Abstract
Ten new B-ring aromatized 6/6/6-tricyclic dearomatized benzocogeijerene-based meroterpenoids with unusual methyl 1,2-shift or demethylation (2-9b), and two new geranylquinol derivatives (1 and 10), together with two known compounds (11 and 12), were isolated from the roots of Arnebia euchroma. Their structures were elucidated by extensive spectroscopic methods, X-ray diffraction crystallography, and ECD calculations. The plausible biosynthetic pathways including the unusual methyl 1,2-shfit and demethylation for B-ring aromatized 6/6/6-tricyclic meroterpenoids were discussed. Compounds 1, 2, 5, 6, 11, and 12 showed significant cardioprotective activities comparable to diltiazem against isoprenaline (ISO)-induced H9C2 cell damage in vitro. Compound 11 probably exerted heart-protective effect on ISO-induced H9C2 cells by modulating the PI3K-AKT-mTOR pathway, reducing excessive autophagy, and decreasing myocardial apoptosis., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF